Vimarsana
Biggest News Aggregation in the World

Page 13 - End Results Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from End Results Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In End Results Program Today - Breaking & Trending Today

Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer - Vimarsana News

Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer

Compared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs.

Source: ajmc.com
Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model - Vimarsana News

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model

Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.

Source: ajmc.com
Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert - Vimarsana News

Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert

Combination of DNA biomarkers with microbiome biomarkers has potential to enhance technical profile of novel pancreatic cancer screening test Joint research project to discover disease specific... | May 10, 2023

EQS-News: Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert - Vimarsana News

EQS-News: Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous Mainz Biomed Partners with Microba Life Sciences for the Development of PancAl...

New USC study shows immigrant adults with liv - Vimarsana News

New USC study shows immigrant adults with liv

Immigrant adults with liver cancer in the United States have higher survival rates than people with the disease who were born in the U.S., according to new research from the USC Norris Comprehensive Cancer Center. Immigrants comprise a significant proportion of those diagnosed with hepatocellular carcinoma in the U.S. Research has shown that birthplace, also referred to as nativity, impacts incidence and risk factors for HCC, but little was known about its influence on survival after diagnosis. The new study, just published in the Journal of the National Cancer Institute, identified a previous...